Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson's disease
- PMID: 26239429
- DOI: 10.3892/mmr.2015.4136
Clinical correlation of peripheral CD4+‑cell sub‑sets, their imbalance and Parkinson's disease
Abstract
Emerging evidence suggests that the peripheral immune system has an active role in the progression of Parkinson's disease (PD). The finding of T‑helper (Th; CD4+) cells infiltrating into the substantia nigra in PD patients demonstrated that Th cells are involved in PD. However, the association between peripheral T‑helper cell sub‑sets (Th1, Th2, Treg and Th17) and the sub‑set balance (Th1/Th2 and Th17/Treg) and PD has remained elusive. In the present study, sixty PD patients of the First Affiliated Hospital of Bengbu Medical College as well as 40 age‑ and environment‑matched healthy individuals were enrolled. The fraction of CD4+ T cells in the peripheral blood was assessed by automated hematology analysis and its sub‑sets (Thl, Th2, Thl7, Treg) were quantified by flow cytometry. The results showed that in the PD group, the proportion of Th1 and Th17 cells was increased, while that of Th2 and Treg cells was decreased. Compared with the control group, the Th1/Th2 and Th17/Treg ratios were significantly enhanced, and shifted towards Th1 and Th17, respectively. Furthermore, this Th1‑type response (Th1/Th2 balance shifting towards Th1) were associated with motor function scores determined by Unified Parkinson's Disease Rating Scale III (UPDRS‑III) scores. However, no correlation was found between the change in the Th17/Treg cell balance (Th17/Treg balance shifting towards Th1) and UPDRS‑III scores. These data supported that chronic immune stimulation, specifically CD4+‑cell sub‑set imbalance, is linked to PD pathobiology and disease severity. CD4+‑cell sub‑sets and their imbalance may therefore represent novel biomarkers or therapeutic targets for PD.
Similar articles
-
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients.J Neuroinflammation. 2018 Jul 12;15(1):205. doi: 10.1186/s12974-018-1248-8. J Neuroinflammation. 2018. PMID: 30001736 Free PMC article.
-
Clinical characteristics and peripheral T cell subsets in Parkinson's disease patients with constipation.Int J Clin Exp Pathol. 2015 Mar 1;8(3):2495-504. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26045755 Free PMC article.
-
Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma.Chin Med J (Engl). 2011 Jul 5;124(13):1951-6. Chin Med J (Engl). 2011. PMID: 22088452
-
Role of distinct CD4(+) T helper subset in pathogenesis of oral lichen planus.J Oral Pathol Med. 2016 Jul;45(6):385-93. doi: 10.1111/jop.12405. Epub 2015 Dec 23. J Oral Pathol Med. 2016. PMID: 26693958 Review.
-
Overview of orchestration of CD4+ T cell subsets in immune responses.Adv Exp Med Biol. 2014;841:1-13. doi: 10.1007/978-94-017-9487-9_1. Adv Exp Med Biol. 2014. PMID: 25261202 Review.
Cited by
-
CD4 T-cell aging exacerbates neuroinflammation in a late-onset mouse model of amyotrophic lateral sclerosis.J Neuroinflammation. 2024 Jan 11;21(1):17. doi: 10.1186/s12974-023-03007-1. J Neuroinflammation. 2024. PMID: 38212835 Free PMC article.
-
Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved.J Neuroinflammation. 2019 Nov 11;16(1):212. doi: 10.1186/s12974-019-1606-1. J Neuroinflammation. 2019. PMID: 31711508 Free PMC article.
-
Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson's disease.J Neurol. 2022 Oct;269(10):5368-5381. doi: 10.1007/s00415-022-11190-z. Epub 2022 May 24. J Neurol. 2022. PMID: 35608657 Free PMC article.
-
JKAP relates to disease risk, severity, and Th1 and Th17 differentiation in Parkinson's disease.Ann Clin Transl Neurol. 2021 Sep;8(9):1786-1795. doi: 10.1002/acn3.51420. Epub 2021 Jul 21. Ann Clin Transl Neurol. 2021. PMID: 34289265 Free PMC article.
-
Crocin restores the balance of Th1/Th2 immune cell response in ConA-treated human lymphocytes.Pharmacol Rep. 2022 Jun;74(3):513-522. doi: 10.1007/s43440-022-00362-3. Epub 2022 Mar 16. Pharmacol Rep. 2022. PMID: 35294736
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials